Omission of axillary lymph node dissection in patients with ypN+ breast cancer after neoadjuvant chemotherapy: A retrospective multicenter study (KROG 21-06)-Reference-Cited by-同舟云学术

Omission of axillary lymph node dissection in patients with ypN+ breast cancer after neoadjuvant chemotherapy: A retrospective multicenter study (KROG 21-06)

Published:2023-03 Issue:3 Volume:49 Page:589-596
ISSN:0748-7983
Container-title:European Journal of Surgical Oncology
language:en
Short-container-title:European Journal of Surgical Oncology

Author:

Park Younghee,Shin Young Seob^ORCID,Kim Kyubo,Shin Kyung Hwan,Chang Ji Hyun,Kim Su Ssan,Jung Jin Hong,Park Won,Kim Haeyoung^ORCID,Kim Yong Bae,Ahn Sung Ja^ORCID,Kim Myungsoo^ORCID,Kim Jin Hee,Cha Hye Jung,Kim Tae Gyu,Park Hae Jin,Lee Sun Young

Funder

National Cancer Center

Ministry of Health and Welfare

Publisher

Elsevier BV

Subject

Oncology,General Medicine,Surgery

Reference21 articles.

1. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial;Galimberti;Lancet Oncol,2013

2. Sentinel node biopsy compared with complete axillary dissection for staging early breast cancer with clinically negative lymph nodes: results of randomized trial;Canavese;Ann Oncol : official journal of the European Society for Medical Oncology,2009

3. Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial;Krag;Lancet Oncol,2007

4. Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study;Veronesi;Lancet Oncol,2006

5. Axillary dissection vs No axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial;Giuliano;JAMA,2011

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Surgery paradigm for locally advanced breast cancer following neoadjuvant systemic therapy;Frontiers in Surgery;2024-09-06

2. Omission of Axillary Lymph Node Dissection in Patients with Residual Nodal Disease After Neoadjuvant Chemotherapy;Annals of Surgical Oncology;2024-09-04

3. De-escalating axillary management after neoadjuvant chemotherapy in breast cancer: The ratio of positive sentinel lymph nodes matters;Surgical Oncology;2024-06

4. The neoadjuvant approach to treatment of breast cancer: Multidisciplinary management to improve outcomes;Surgical Oncology Insight;2024-06

5. Omission of Axillary Dissection in Node Positive Breast Cancer After Neoadjuvant Systemic Therapy;Journal of Surgical Research;2023-12